We conducted a prospective survey of the utilization of venous thromboembolism (VTE) prophylaxis in 152 Medical ICU (MICU) patients. Utilization of prophylaxis was recorded daily, and commonly accepted risk factors for VTE were noted. Only 32.9 percent of patients received prophylaxis, and there was a delay of 2.0 ± 2.8 days prior to institution. Eighty 
We conducted a prospective survey of the utilization of venous thromboembolism (VTE) prophylaxis in 152 Medical ICU (MICU) patients. Utilization of prophylaxis was recorded daily, and commonly accepted risk factors for VTE were noted. Only 32.9 percent of patients received prophylaxis, and there was a delay of 2.0 ± 2.8 days prior to institution. Eighty-seven percent of patients had one VTE risk factor and 52 percent had multiple factors. We conclude that utilization of pro-V enous thromboembolism (VTE) is responsible for more than 250,000 hospitalizations annually in the United States.1 Recognized risk factors for VTE include immobilization as well as concomitant medical illnesses such as cancer, acute myocardial infarction, and respiratory failure.23 In a 1978 retrospective study of respiratory ICU patients, 27 percent had pulmonary emboli at autopsy.4 Despite these recognized risks, overall use of prophylaxis measures occurs in only 32 percent of high-risk medical and surgical patients in the general inpatient population, according to a retrospective survey by Anderson et al. 5 The specific utilization rate of prophylaxis has not been studied often in a wide range of medical patients.6 To '7 In comparison with their retrospective survey, which included both medical and surgical patients, our patient population was limited to a medical critical care setting, surveyed prospectively. The 33 percent prevalence of overall prophylaxis use in our study is almost identical to that found in the general population in the survey of Anderson et a15 of physician utilization of prophylaxis (32 percent). In our study, utilization of prophylaxis in patients with 3 or more risk factors was 48 percent, which is similar to the 44 percent rate of prophylaxis in the teaching hospitals studied by Anderson et al.5 Our survey is one of few which has focused on a population of critically ill medical patients. While VTE prophylaxis has become standard practice for virtually all surgical patients at our hospital, we have now found that the majority of MICU patients do not receive VTE prophylaxis.
